Tanvir Bell, MD
Basic profileThe University of Texas Health Science Center at Houston
Tanvir Bell is an Infectious Disease physician affiliated with The University of Texas Health Science Center at Houston. OpenAlex indexes 16 publications with 302 citations (h-index 7); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6410 Fannin St
604
Houston, TX 770303000
Telephone
832-325-7070Registry record last updated 12 Jul 2007.
Clinical trials
- Evaluation of Barriers to Postpartum Care in HIV Infected Women
Sponsor: The University of Texas Health Science Center, Houston
- Evaluation of Cardiovascular Effects of Smoking Cessation in HIV Patients
Sponsor: The University of Texas Health Science Center, Houston
- Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients
Sponsor: The University of Texas Health Science Center, Houston
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
1 NIH research award on record, funded 2005–2005 per NIH RePORTER. The latest:
- ACTG A5164: A PHASE IV STUDY OF ANTIRETROVIRAL THERAPY FOR HIV-INFECTED ADULTS
University of Texas Medical Br Galveston
FY2005$1,283M01RR000073
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Brief Report: Low-Dose Methotrexate Does Not Affect Measures of HIV-1 Persistence in Individuals With Chronically Treated HIV-1 Infection
JAIDS Journal of Acquired Immune Deficiency Syndromes
2024 - Age Differences by Sex in Antiretroviral-Naïve Participants: Pooled Analysis from Randomized Clinical Trials
Journal of the Association of Nurses in AIDS Care
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Frank Arnett, MD
The University of Texas Health Science Center at Houston
Ali Marian, MD
The University of Texas Health Science Center at Houston
Anjail Sharrief, MD
The University of Texas Health Science Center at Houston
Heidi Russell, MD
The University of Texas Health Science Center at Houston
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”